Accelerating accessible
early cancer detection
Powered by OncoSeek®
Advancing multi-cancer detection
Worldwide, 19.3 million people are diagnosed with cancer each year, and the numbers are growing. Nearly one in six deaths is caused by cancer. Detecting cancer earlier increases chances of survival and reduces the negative impact on quality of life. OncoInv supports the implementation of structured multi-cancer detection programs using the OncoSeek® blood test.
OncoSeek® is a clinically validated and scalable blood test for cancer detection
OncoSeek® is a software-based blood test that analyses protein tumor marker concentrations using a machine learning algorithm. The test detects nine high-mortality cancer types and provides both a Probability of Cancer score and a predicted Tissue of Origin. OncoSeek® is scientifically validated, CE-marked, and designed to integrate into existing healthcare settings.
About Oncolnv
OncoInv is an initiative of Inspire2Live. Our mission is to improve access to cancer treatment worldwide through earlier cancer detection. OncoInv collaborates with SeekIn, the developer of OncoSeek®, to support that mission.
News & Updates
